Content about Health & Wellness

June 30, 2011

As part of this year's National Association of Chain Drug Stores Marketplace Conference in Boston, which came to a close Tuesday, NACDS conference exhibitors and Conventions C.A.R.E. dispersed 6.5 tons of consumer goods to various charitable organizations throughout the Greater Boston community.

ALEXANDRIA, Va. — As part of this year's National Association of Chain Drug Stores Marketplace Conference in Boston, which came to a close Tuesday, NACDS conference exhibitors and Conventions C.A.R.E. dispersed 6.5 tons of consumer goods to various charitable organizations throughout the Greater Boston community.

June 30, 2011

A group of physicians is urging the Food and Drug Administration not to approve a drug made by Gilead Sciences for the prevention of HIV infection.

LOS ANGELES — A group of physicians is urging the Food and Drug Administration not to approve a drug made by Gilead Sciences for the prevention of HIV infection.

Fifty-five physicians signed a letter spearheaded by the AIDS Healthcare Foundation citing concerns about the use of Gilead’s Truvada (tenofovir disoproxil fumarate and emtricitabine) for “pre-exposure prophylaxis,” or PrEP. Concerns included the risk of a decrease in condom use and a lack of information showing proper use in “real world” situations.

June 30, 2011

A new study that combined three separate cohorts conducted by researchers at the Harvard School of Public Health found that such lifestyle factors as diet may influence long-term weight gain.

BOSTON — A new study that combined three separate cohorts conducted by researchers at the Harvard School of Public Health found that such lifestyle factors as diet may influence long-term weight gain.

The study pooled data from 120,877 U.S. women and men who were free of chronic diseases and not obese at the beginning of the study, with follow-up periods from 1986 to 2006, 1991 to 2003, and 1986 to 2006. Patients were followed up at four-year intervals, researchers said.

June 30, 2011

Canadian drug maker Valeant Pharmaceuticals International will acquire rights to topical drugs for eczema and cold sores from Swedish drug maker Meda.

MISSISSAUGA, Ontario — Canadian drug maker Valeant Pharmaceuticals International will acquire rights to topical drugs for eczema and cold sores from Swedish drug maker Meda.

Valeant said it would buy rights for the eczema drug Elidel (pimecrolimus) and the cold sore drug Xerese (acyclovir and hydrocortisone) for the United States, Canada and Mexico. Valeant said, however, that Xerese has not yet received regulatory approval in Canada.

June 29, 2011

Adding an investigational drug for Type 2 diabetes to the common generic drug metformin helped control blood sugar in patients who could not control their blood sugar with metformin alone, according to results of a late-stage clinical study.

SAN DIEGO — Adding an investigational drug for Type 2 diabetes to the common generic drug metformin helped control blood sugar in patients who could not control their blood sugar with metformin alone, according to results of a late-stage clinical study.

June 29, 2011

Important safety information often is missing from drug labels, while some pharmacies don’t include medication guides required by the federal government, according to a new investigation by Consumer Reports.

YONKERS, N.Y. — Important safety information often is missing from drug labels, while some pharmacies don’t include medication guides required by the federal government, according to a new investigation by Consumer Reports.

June 29, 2011

Sens. Jerry Moran, R-Kan., and Jon Tester, D-Mont., have established the first-ever Senate Community Pharmacy Caucus, an effort endorsed Wednesday by the National Community Pharmacists Association.

ALEXANDRIA, Va. — Sens. Jerry Moran, R-Kan., and Jon Tester, D-Mont., have established the first-ever Senate Community Pharmacy Caucus, an effort endorsed Wednesday by the National Community Pharmacists Association.

NCPA’s efforts to help establish a Senate Pharmacy Caucus were reported one month ago here.

June 29, 2011

A topical drug made by Eli Lilly restored testosterone to normal levels in men with abnormally low testosterone, according to results of a late-stage clinical trial.

INDIANAPOLIS — A topical drug made by Eli Lilly restored testosterone to normal levels in men with abnormally low testosterone, according to results of a late-stage clinical trial.

Lilly announced results of a phase-3 trial of Axiron (testosterone) topical solution, a treatment for the condition, also known as hypogonadism. Study results also showed that the drug improved symptoms associated with it.

Hypogonadism results from damage or disease of the testicles, hypothalamus or pituitary glands that inhibits production of testosterone.

June 29, 2011

Tracking medication adherence and connecting to pharmacies when it's time to refill prescriptions are among the capabilities of a new iPhone and iPad application made by GreatCall.

SAN DIEGO — Tracking medication adherence and connecting to pharmacies when it's time to refill prescriptions are among the capabilities of a new iPhone and iPad application made by GreatCall.

GreatCall announced the launch of MedCoach, a medication management app that the company said would help customers better manage their overall well-being for free.

June 29, 2011

Meijer's free prenatal vitamins prescription program filled its 1 millionth prescription this week, the company announced Wednesday.

GRAND RAPIDS, Mich. — Meijer's free prenatal vitamins prescription program filled its 1 millionth prescription this week, the company announced Wednesday.

The retailer said that its program, which launched in May 2008, has garnered nearly $14 million in savings to Midwest families. The Meijer free prenatal vitamins program offers such brands as TriAdvance, Trinatal GT, Trinatal Ultra, Vol-Nate, Vol-Plus and Vol-Tab, and enables any customer, regardless of insurance or copay, to have his or her prenatal prescription filled free of charge.

June 29, 2011

McNeil Consumer Healthcare on Tuesday initiated another recall at the retail level of one product lot (60,912 bottles) of Tylenol extra strength caplets in 225-count bottles because of a small number of odor reports, including a musty, moldy odor.

FORT WASHINGTON, Pa. — McNeil Consumer Healthcare on Tuesday initiated another recall at the retail level of one product lot (60,912 bottles) of Tylenol extra strength caplets in 225-count bottles because of a small number of odor reports, including a musty, moldy odor.

The uncharacteristic musty, moldy odor has been linked to the presence of trace amounts of a chemical known as 2,4,6-tribromoanisole (TBA).

The product lot number (ABA619) for the recalled product can be found on the side of the bottle label. The recalled product was manufactured in February 2009.

June 29, 2011

Legislation has been introduced that would require stricter labeling requirements of cosmetics and personal care products and give the Food and Drug Administration recall authority for products that are misbranded, adulterated or otherwise fail to meet safety standards.

WASHINGTON — Legislation has been introduced that would require stricter labeling requirements of cosmetics and personal care products and give the Food and Drug Administration recall authority for products that are misbranded, adulterated or otherwise fail to meet safety standards.

June 29, 2011

Sam's Club is helping parents prepare for the back-to-school season by offering free children's health and ID screenings at stores nationwide on July 9.

BENTONVILLE, Ark. — Sam's Club is helping parents prepare for the back-to-school season by offering free children's health and ID screenings at stores nationwide on July 9.

June 28, 2011

A cobranded Type 2 diabetes treatment may help reduce blood-sugar levels among patients when combined with insulin (with or without metformin), according to a late-stage clinical trial.

SAN DIEGO — A cobranded Type 2 diabetes treatment may help reduce blood-sugar levels among patients when combined with insulin (with or without metformin), according to a late-stage clinical trial.

AstraZeneca and Bristol-Myers Squibb said that when Onglyza (saxagliptin) in the 5-mg strength was combined with insulin (with or without metformin), patients saw significantly lower HbA1C levels by an average of about 0.73% by the end of the phase-3 trial, compared with a placebo-insulin (with or without metformin) combination.

June 28, 2011

Skin care brand Eucerin has introduced a tool that helps consumers understand the financial benefits of good skin care habits.

WILTON, Conn. — Skin care brand Eucerin has introduced a tool that helps consumers understand the financial benefits of good skin care habits.

June 28, 2011

A subsidiary of Johnson & Johnson and Gilead Sciences will collaborate to develop a combination drug for HIV, the two companies said Tuesday.

CORK, Ireland — A subsidiary of Johnson & Johnson and Gilead Sciences will collaborate to develop a combination drug for HIV, the two companies said Tuesday.

Gilead and Tibotec Pharmaceuticals will work to create a once-daily, single-tablet combination of Tibotec’s Prezista (darunavir) and Gilead’s investigational drug cobicistat, a so-called boosting agent.

June 28, 2011

An investigational Sanofi drug for diabetes works at least as well as a similar treatment already on the market, and results in less abnormally low blood sugar, according to late-stage clinical trial results presented at the American Diabetes Association’s 71st Scientific Sessions in San Diego this past weekend.

PARIS — An investigational Sanofi drug for diabetes works at least as well as a similar treatment already on the market, and results in less abnormally low blood sugar, according to late-stage clinical trial results presented at the American Diabetes Association’s 71st Scientific Sessions in San Diego this past weekend.

June 28, 2011

A new multimedia public service campaign that is designed to help families prevent food poisoning in the home has made its debut.

WASHINGTON — A new multimedia public service campaign that is designed to help families prevent food poisoning in the home has made its debut.

June 28, 2011

A new study indicated that two insulin products made by French drug maker Sanofi lower blood-glucose levels to a greater extent than premixed insulin, and with improvements in quality of life and less hypoglycemia.

PARIS — A new study indicated that two insulin products made by French drug maker Sanofi lower blood-glucose levels to a greater extent than premixed insulin, and with improvements in quality of life and less hypoglycemia.

Sanofi announced results of the 60-week study, which compared regimens, including Lantus (insulin glargine [rDNA origin]) and Apidra (insulin glulisine [rDNA origin]).

June 28, 2011

New data from a late-stage clinical trial of a recently approved drug for Type 2 diabetes show improved blood-sugar control in adults who take it with metformin or alone.

SAN DIEGO — New data from a late-stage clinical trial of a recently approved drug for Type 2 diabetes show improved blood-sugar control in adults who take it with metformin or alone.

Boehringer Ingelheim and Eli Lilly presented data from the study of Tradjenta (linagliptin) at the American Diabetes Association’s 71st Scientific Sessions in San Diego last weekend. The study showed reductions in blood sugar and weight, and a low incidence of abnormally low blood sugar, known as hypoglycemia.

The FDA approved Tradjenta as a treatment for Type 2 diabetes in May.

June 27, 2011

Abbott Diabetes Care reported Friday that a shipment of blood-glucose monitoring products was reported stolen from a shipping carrier facility in Louisville, Ky., on June 19.

ALAMEDA, Calif. — Abbott Diabetes Care reported Friday that a shipment of blood-glucose monitoring products was reported stolen from a shipping carrier facility in Louisville, Ky., on June 19.

June 27, 2011

Use of a drug for Type 2 diabetes made by Eli Lilly and Amylin Pharmaceuticals may lower patients’ risk of heart failure, according to a new study.

SAN DIEGO — Use of a drug for Type 2 diabetes made by Eli Lilly and Amylin Pharmaceuticals may lower patients’ risk of heart failure, according to a new study.

The study of more than 778,000 patients taking the injected drug Byetta (exenatide) found that adding the drug to a pre-existing diabetes regimen, especially if that regimen included insulin, was associated with reduced likelihood of heart failure. Results were presented Saturday at the 71st Scientific Sessions of the American Diabetes Association in San Diego.

June 27, 2011

The Food and Drug Administration has accepted a regulatory approval application for a drug designed to prevent premature birth in pregnant women.

LIVINGSTON, N.J. — The Food and Drug Administration has accepted a regulatory approval application for a drug designed to prevent premature birth in pregnant women.

Columbia Labs and Watson Pharmaceuticals announced Monday that the FDA would review their application for Prochieve (progesterone gel) for the reduction of risk of preterm birth in women with short uterine cervical length in the third trimester of pregnancy.

June 27, 2011

Fera Pharmaceuticals has launched an ocular bacterial infections treatment.

NEW YORK — Fera Pharmaceuticals has launched an ocular bacterial infections treatment.

The company announced the launch of Garamycin (gentamicin sulfate) ophthalmic solution USP, designed to treat such infections as conjunctivitis, keratitis and blepharitis.

Last year, Fera broadened its Garamycin product offerings with the launch of preservative-free Garamycin ophthalmic ointment.

June 27, 2011

Novo Nordisk unveiled data from two extension studies at the 71st annual Scientific Sessions of the American Diabetes Association in San Diego that show its diabetes drug, when combined with other medications, may help patients achieve blood-sugar control.

SAN DIEGO — Novo Nordisk unveiled data from two extension studies at the 71st annual Scientific Sessions of the American Diabetes Association in San Diego that show its diabetes drug, when combined with other medications, may help patients achieve blood-sugar control.

The drug maker found that combining Victoza (liraglutide [rDNA origin] injection) with metformin and/or sulfonylurea helped patients achieve blood-sugar control.